| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer.
|
Clin Cancer Res
|
2009
|
4.47
|
|
2
|
Pten in stromal fibroblasts suppresses mammary epithelial tumours.
|
Nature
|
2009
|
4.21
|
|
3
|
Inflammatory breast cancer: the disease, the biology, the treatment.
|
CA Cancer J Clin
|
2010
|
2.45
|
|
4
|
Norepinephrine upregulates VEGF, IL-8, and IL-6 expression in human melanoma tumor cell lines: implications for stress-related enhancement of tumor progression.
|
Brain Behav Immun
|
2008
|
1.71
|
|
5
|
The lymphovascular embolus of inflammatory breast cancer expresses a stem cell-like phenotype.
|
Am J Pathol
|
2008
|
1.49
|
|
6
|
Pseudomyxoma peritonei is a disease of MUC2-expressing goblet cells.
|
Am J Pathol
|
2002
|
1.42
|
|
7
|
Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer.
|
Mol Cancer Ther
|
2009
|
1.36
|
|
8
|
Precancerous stem cells have the potential for both benign and malignant differentiation.
|
PLoS One
|
2007
|
1.36
|
|
9
|
Piwil2 is expressed in various stages of breast cancers and has the potential to be used as a novel biomarker.
|
Int J Clin Exp Pathol
|
2010
|
1.24
|
|
10
|
Cooperative role of E-cadherin and sialyl-Lewis X/A-deficient MUC1 in the passive dissemination of tumor emboli in inflammatory breast carcinoma.
|
Oncogene
|
2002
|
1.18
|
|
11
|
Identification of Piwil2-like (PL2L) proteins that promote tumorigenesis.
|
PLoS One
|
2010
|
1.17
|
|
12
|
Precancerous stem cells can serve as tumor vasculogenic progenitors.
|
PLoS One
|
2008
|
1.14
|
|
13
|
The paradox of E-cadherin: role in response to hypoxia in the tumor microenvironment and regulation of energy metabolism.
|
Oncotarget
|
2013
|
1.13
|
|
14
|
Piwil2 expressed in various stages of cervical neoplasia is a potential complementary marker for p16.
|
Am J Transl Res
|
2010
|
1.13
|
|
15
|
Anatomy of the nipple and breast ducts revisited.
|
Cancer
|
2004
|
1.10
|
|
16
|
Relationship of sialyl-Lewis(x/a) underexpression and E-cadherin overexpression in the lymphovascular embolus of inflammatory breast carcinoma.
|
Am J Pathol
|
2002
|
1.08
|
|
17
|
MUC2 is a molecular marker for pseudomyxoma peritonei.
|
Mod Pathol
|
2002
|
1.05
|
|
18
|
KIAA0101 interacts with BRCA1 and regulates centrosome number.
|
Mol Cancer Res
|
2011
|
1.04
|
|
19
|
ERalpha suppresses slug expression directly by transcriptional repression.
|
Biochem J
|
2008
|
1.03
|
|
20
|
Semi-automated imaging system to quantitate Her-2/neu membrane receptor immunoreactivity in human breast cancer.
|
Cytometry A
|
2007
|
0.99
|
|
21
|
Imaging and analysis of 3D tumor spheroids enriched for a cancer stem cell phenotype.
|
J Biomol Screen
|
2010
|
0.96
|
|
22
|
Identification of a novel endothelial-derived gene EG-1.
|
Biochem Biophys Res Commun
|
2002
|
0.96
|
|
23
|
Presence of anaplastic lymphoma kinase in inflammatory breast cancer.
|
Springerplus
|
2013
|
0.92
|
|
24
|
Inhibition of expression of the chromatin remodeling gene, SNF2L, selectively leads to DNA damage, growth inhibition, and cancer cell death.
|
Mol Cancer Res
|
2009
|
0.91
|
|
25
|
Novel interactions of vitamin E and estrogen in breast cancer.
|
Nutr Cancer
|
2005
|
0.91
|
|
26
|
Reversible model of spheroid formation allows for high efficiency of gene delivery ex vivo and accurate gene assessment in vivo.
|
Hum Gene Ther
|
2002
|
0.89
|
|
27
|
Breast carcinomatous tumoral emboli can result from encircling lymphovasculogenesis rather than lymphovascular invasion.
|
Oncotarget
|
2010
|
0.87
|
|
28
|
A cluster of inflammatory breast cancer (IBC) in an office setting: additional evidence of the importance of environmental factors in IBC etiology.
|
Oncol Rep
|
2010
|
0.87
|
|
29
|
E-cadherin accumulation within the lymphovascular embolus of inflammatory breast cancer is due to altered trafficking.
|
Anticancer Res
|
2010
|
0.84
|
|
30
|
Expression of a mutant p53 results in an age-related demographic shift in spontaneous lung tumor formation in transgenic mice.
|
PLoS One
|
2009
|
0.83
|
|
31
|
A bispecific EpCAM/CD133-targeted toxin is effective against carcinoma.
|
Target Oncol
|
2013
|
0.83
|
|
32
|
Clinicopathologic analysis of sentinel lymph node mapping in early breast cancer.
|
Breast J
|
2003
|
0.79
|
|
33
|
A novel mechanism of indole-3-carbinol effects on breast carcinogenesis involves induction of Cdc25A degradation.
|
Cancer Prev Res (Phila)
|
2010
|
0.77
|
|
34
|
Angiosarcoma developing in a breast after conservation treatment for breast cancer.
|
Am J Clin Oncol
|
2003
|
0.76
|
|
35
|
Singular v dual inhibition of SNF2L and its isoform, SNF2LT, have similar effects on DNA damage but opposite effects on the DNA damage response, cancer cell growth arrest and apoptosis.
|
Oncotarget
|
2012
|
0.76
|
|
36
|
Early to intermediate steps of tumor embolic formation involve specific proteolytic processing of E-cadherin regulated by Rab7.
|
Mol Cancer Res
|
2012
|
0.75
|
|
37
|
Atypical ductal hyperplasia presenting as pseudomicrocalcifications.
|
Breast J
|
2003
|
0.75
|
|
38
|
Comparative oncological studies of feline bronchioloalveolar lung carcinoma, its derived cell line and xenograft.
|
Cancer Res
|
2002
|
0.75
|
|
39
|
Establishment of an immortalized cell line and transplantable xenograft from a bronchioloalveolar lung carcinoma of a cat.
|
Am J Vet Res
|
2002
|
0.75
|